PET and PET-CT of lung cancer - PubMed (original) (raw)
PET and PET-CT of lung cancer
Hans C Steinert. Methods Mol Biol. 2011.
Abstract
Accurate staging is essential to offer the patient the most effective available treatment and the best estimate of prognosis. In non-small cell lung cancer (NSCLC), surgical resection offers the best chance of cure in the early stages, either alone or in combination with chemo- or radiotherapy at the more advanced stages. However, many patients present with metastatic disease at the time of diagnosis. Both computed tomography (CT) and positron emission tomography (PET) using fluorodeoxyglucose (FDG) play an important role in the diagnosis and staging of lung cancer. CT provides excellent morphologic information but has significant limitations in differentiating between benign and malignant lesions either in an organ or in lymph nodes. FDG-PET is highly accurate in the detection of mediastinal lymph node metastases as well as extratharacic metastases. However, due to the poor anatomic information provided by PET, additional morphologic information is needed to properly locate a lesion. Imaging with PET integrated with computed tomography (PET/CT) offers essential advantages in comparison to PET alone, CT alone, or visual correlation of separate PET and CT. A combined PET/CT system provides PET and CT images perfectly coregistered so that lesions can be exactly localized.
Similar articles
- Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography.
Harders SW, Madsen HH, Hjorthaug K, Arveschoug AK, Rasmussen TR, Meldgaard P, Hoejbjerg JA, Pilegaard HK, Hager H, Rehling M, Rasmussen F. Harders SW, et al. Cancer Imaging. 2014 Jun 3;14(1):23. doi: 10.1186/1470-7330-14-23. Cancer Imaging. 2014. PMID: 25608616 Free PMC article. - Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K. Kanzaki R, et al. Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1009-14. doi: 10.1510/icvts.2009.227538. Epub 2010 Mar 2. Interact Cardiovasc Thorac Surg. 2010. PMID: 20197344 - PET-CT in radiotherapy for lung cancer.
De Ruysscher D. De Ruysscher D. Methods Mol Biol. 2011;727:53-8. doi: 10.1007/978-1-61779-062-1_4. Methods Mol Biol. 2011. PMID: 21331928 - Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F. Billé A, et al. Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Eur J Cardiothorac Surg. 2009. PMID: 19464906 Review. - PET versus PET/CT dual-modality imaging in evaluation of lung cancer.
Freudenberg LS, Rosenbaum SJ, Beyer T, Bockisch A, Antoch G. Freudenberg LS, et al. Radiol Clin North Am. 2007 Jul;45(4):639-44, v. doi: 10.1016/j.rcl.2007.05.003. Radiol Clin North Am. 2007. PMID: 17706528 Review.
Cited by
- The Prognostic Value of Positron Emission Tomography/Computed Tomography in Clinical Stage I Lung Cancer Patients: A Propensity-Match Analysis.
Cheng YF, Huang JY, Lin CH, Lin SH, Wang BY. Cheng YF, et al. J Clin Med. 2024 Apr 21;13(8):2416. doi: 10.3390/jcm13082416. J Clin Med. 2024. PMID: 38673689 Free PMC article. - The flip-flop fungus sign: an FDG PET/CT sign of benignity.
Nagelschneider AA, Broski SM, Holland WP, Midthun DE, Sykes AM, Lowe VJ, Peller PJ, Johnson GB. Nagelschneider AA, et al. Am J Nucl Med Mol Imaging. 2017 Nov 1;7(5):212-217. eCollection 2017. Am J Nucl Med Mol Imaging. 2017. PMID: 29181268 Free PMC article. - PET/CT in the staging of the non-small-cell lung cancer.
Chao F, Zhang H. Chao F, et al. J Biomed Biotechnol. 2012;2012:783739. doi: 10.1155/2012/783739. Epub 2012 Mar 7. J Biomed Biotechnol. 2012. PMID: 22577296 Free PMC article. Review. - Prognostic potential of integrated morphologic and metabolic parameters of pre-therapeutic [18F]FDG-PET/CT regarding progression-free survival (PFS) and overall survival (OS) in NSCLC-patients.
Peters HA, Weiss D, Boschheidgen M, Mamlins E, Giesel FL, Fluegen G, Kirchner J, Antoch G, Jannusch K. Peters HA, et al. PLoS One. 2024 Jul 29;19(7):e0307998. doi: 10.1371/journal.pone.0307998. eCollection 2024. PLoS One. 2024. PMID: 39074093 Free PMC article. - The value of ultrasound-guided biopsy of fluorodeoxy-glucose positron emission tomography (FDG-PET)-positive supraclavicular lymph nodes in patients with suspected lung cancer.
Werner L, Keller FA, Bhure U, Roos JE, Tornquist K, Del Sol Pèrez-Lago M, Gautschi O, Strobel K. Werner L, et al. BMC Med Imaging. 2017 Jul 11;17(1):41. doi: 10.1186/s12880-017-0214-8. BMC Med Imaging. 2017. PMID: 28693444 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical